AIDS and the FDA: an ethical case for limiting patient access to new medical therapies.
D000163:Acquired Immunodeficiency Syndrome; D000533:Altruism; D026686:Beneficence; D000529:Complementary Therapies; D003657:Decision Making; D015507:Drugs, Investigational; D004989:Ethics; D035082:Federal Government; D005610:Freedom; D006076:Government; D033161:Government Regulation; D006679:HIV Seropositivity; D006805:Human Experimentation; D006806:Human Rights; D006801:Humans; D033181:Information Dissemination; D007255:Information Services; D007258:Informed Consent; D007348:Insurance, Health; D016743:Mental Competency; D026706:Paternalism; D005791:Patient Care; D010361:Patients; D026684:Personal Autonomy; D011050:Policy Making; D011057:Politics; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012935:Social Justice; D019452:Terminally Ill; D014481:United States; D014486:United States Food and Drug Administration
Analytical Approach; Biomedical and Behavioral Research; Health Care and Public Health; Professional Patient Relationship